Vincamine

This classification denotes a cns stimulant with the molecular formula C21H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 996XVD0JHT, chemically known as methyl (3alpha,14alpha,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate but generally known as vincamine, which bears US NIH Compound Identifier 5668. European Medicines Agency schedules Vincamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00054MIG. The term VINCAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules vincamine in its Anatomical Therapeutic Chemical (ATC) Classification. VINCAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vincamine under HS 29399900 and SITC 54149. As of Q4 2014, VINCAMINE remains the US FDA Preferred Term for this commodity. Vincamine bears US NLM identifiers UMLS ID C0042674 and NCI Concept Code C87697. SMILES: OC1(n2c3C4N(CCCC4(C1)CC)CCc3c1c2cccc1)C(=O)OC.